
    
      The investigators will select 600 cases of women with breast cancer of triple negative or
      Her-2 positive or with more than 4 axillary lymph node metastasis. All the patients were
      accepted the chemotherapy of Anthracycline and/or Taxane. Divide them into two groups
      randomly. Then the experimental group will be treated with Xeloda(1000mg/m2,orally,2
      times/day) for six cycles (21 days/cycle,each taking two weeks suspending for one week) as
      Sequential Adjuvant Therapy. And the control group will not receive any adjuvant
      therapy.Finally the investigators will assess the 5-year disease-free survival, 5 years and
      10-year overall survival and safety of using medications.
    
  